Evidence map›Paper›PMID 34507859›Full record

ArticleVaccine2021

The impact of COVID-19 vaccination delay: A data-driven modeling analysis for Chicago and New York City.

Vinicius V L Albani, Jennifer Loria, Eduardo Massad, Jorge P Zubelli

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Assessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution.Journal of urban health : bulletin of the New York Academy of Medicine · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Urban Determinants of COVID-19 Spread: a Comparative Study across Three Cities in New York State.Journal of urban health : bulletin of the New York Academy of Medicine · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. On the mass COVID-19 vaccination scheduling problem.Computers & operations research · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Vinicius V L AlbaniFederal University of Santa Catarina, 88.040-900 Florianopolis, Brazil. Electronic address: v.albani@ufsc.br.
Jennifer LoriaInstituto de Matemática Pura e Aplicada, Rio de Janeiro, Brazil; Universidad de Costa Rica, San José, Costa Rica. Electronic address: jennyls@impa.br.
Eduardo MassadSchool of Medicine, University of São Paulo and LIM01-HCFMUSP, São Paulo, Brazil; School of Applied Mathematics, Fundação Getúlio Vargas, Rio de Janeiro, Brazil. Electronic address: eduardo.massad@fgv.br.
Jorge P ZubelliMathematics Department, Khalifa University, Abu Dhabi, UAE. Electronic address: jorge.zubelli@ku.ac.ae.
Instituto Nacional de Matemática Pura e Aplicada · BRKhalifa University of Science and Technology · AEUniversidade de São Paulo · BRUniversidade Federal de Santa Catarina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBy the beginning of December 2020, some vaccines against COVID-19 already presented efficacy and security, which qualify them to be used in mass vaccination campaigns. Thus, setting up strategies of vaccination became crucial to control the COVID-19 pandemic.

methodsWe use daily COVID-19 reports from Chicago and New York City (NYC) from 01-Mar2020 to 28-Nov-2020 to estimate the parameters of an SEIR-like epidemiological model that accounts for different severity levels. To achieve data adherent predictions, we let the model parameters to be time-dependent. The model is used to forecast different vaccination scenarios, where the campaign starts at different dates, from 01-Oct-2020 to 01-Apr-2021. To generate realistic scenarios, disease control strategies are implemented whenever the number of predicted daily hospitalizations reaches a preset threshold.

resultsThe model reproduces the empirical data with remarkable accuracy. Delaying the vaccination severely affects the mortality, hospitalization, and recovery projections. In Chicago, the disease spread was under control, reducing the mortality increment as the start of the vaccination was postponed. In NYC, the number of cases was increasing, thus, the estimated model predicted a much larger impact, despite the implementation of contention measures. The earlier the vaccination campaign begins, the larger is its potential impact in reducing the COVID-19 cases, as well as in the hospitalizations and deaths. Moreover, the rate at which cases, hospitalizations and deaths increase with the delay in the vaccination beginning strongly depends on the shape of the incidence of infection in each city.

Indexed as

COVID-19COVID-19 VaccinesChicagoHumansNew York CityPandemicsSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19Epidemiological modelsPublic health strategiesSEIR-type modelsVaccination

Identifiers

PMID34507859
PMCPMC8405507
OpenAlexW3196933489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.